Cargando…
GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
Previous studies indicated that G-protein coupled receptor 174 (GPR174) is involved in the dysregulated immune response of sepsis, however, the clinical value and effects of GPR174 in septic patients are still unknown. This study is aimed to evaluate the potential value of GPR174 as a prognostic bio...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841418/ https://www.ncbi.nlm.nih.gov/pubmed/35173706 http://dx.doi.org/10.3389/fimmu.2021.789141 |
_version_ | 1784650831474196480 |
---|---|
author | Wang, Jianli Hu, Yanyan Kuang, Zhongshu Chen, Yao Xing, Lingyu Wei, Wei Xue, Mingming Mu, Sucheng Tong, Chaoyang Yang, Yilin Song, Zhenju |
author_facet | Wang, Jianli Hu, Yanyan Kuang, Zhongshu Chen, Yao Xing, Lingyu Wei, Wei Xue, Mingming Mu, Sucheng Tong, Chaoyang Yang, Yilin Song, Zhenju |
author_sort | Wang, Jianli |
collection | PubMed |
description | Previous studies indicated that G-protein coupled receptor 174 (GPR174) is involved in the dysregulated immune response of sepsis, however, the clinical value and effects of GPR174 in septic patients are still unknown. This study is aimed to evaluate the potential value of GPR174 as a prognostic biomarker for sepsis and explore the pathological function of GPR174 in cecal ligation and puncture (CLP)-induced septic mice. In this prospective longitudinal study, the expressions of peripheral GPR174 mRNA were measured in 101 septic patients, 104 non-septic ICU controls, and 46 healthy volunteers at Day 1, 7 after ICU (Intensive Care Unit) admission, respectively. Then, the clinical values of GPR174 for the diagnosis, severity assessment, and prognosis of sepsis were analyzed. Moreover, the expressions of GPR174 mRNA in CLP-induced septic mice were detected, and Gpr174-knockout (KO) mice were used to explore its effects on inflammation. The results showed that the levels of GPR174 mRNA were significantly decreased in septic patients compared with non-septic ICU and healthy controls. In addition, the expressions of GPR174 mRNA were correlated with the lymphocyte (Lym) counts, C-reactive protein (CRP), and APACHE II and SOFA scores. The levels of GPR174 mRNA at Day 7 had a high AUC in predicting the death of sepsis (0.83). Further, we divided the septic patients into the higher and lower GPR174 mRNA expression groups by the ROC cut-off point, and the lower group was significantly associated with poor survival rate (P = 0.00139). Similarly, the expressions of peripheral Gpr174 mRNA in CLP-induced septic mice were also significantly decreased, and recovered after 72 h. Intriguingly, Gpr174-deficient could successfully improve the outcome with less multi-organ damage, which was mainly due to an increased level of IL-10, and decreased levels of IL-1β and TNF-α. Further, RNA-seq showed that Gpr174 deficiency significantly induced a phenotypic shift toward multiple immune response pathways in septic mice. In summary, our results indicated that the expressions of GPR174 mRNA were associated with the severity of sepsis, suggesting that GPR174 could be a potential prognosis biomarker for sepsis. In addition, GPR174 plays an important role in the development of sepsis by regulating the inflammatory response. |
format | Online Article Text |
id | pubmed-8841418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88414182022-02-15 GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response Wang, Jianli Hu, Yanyan Kuang, Zhongshu Chen, Yao Xing, Lingyu Wei, Wei Xue, Mingming Mu, Sucheng Tong, Chaoyang Yang, Yilin Song, Zhenju Front Immunol Immunology Previous studies indicated that G-protein coupled receptor 174 (GPR174) is involved in the dysregulated immune response of sepsis, however, the clinical value and effects of GPR174 in septic patients are still unknown. This study is aimed to evaluate the potential value of GPR174 as a prognostic biomarker for sepsis and explore the pathological function of GPR174 in cecal ligation and puncture (CLP)-induced septic mice. In this prospective longitudinal study, the expressions of peripheral GPR174 mRNA were measured in 101 septic patients, 104 non-septic ICU controls, and 46 healthy volunteers at Day 1, 7 after ICU (Intensive Care Unit) admission, respectively. Then, the clinical values of GPR174 for the diagnosis, severity assessment, and prognosis of sepsis were analyzed. Moreover, the expressions of GPR174 mRNA in CLP-induced septic mice were detected, and Gpr174-knockout (KO) mice were used to explore its effects on inflammation. The results showed that the levels of GPR174 mRNA were significantly decreased in septic patients compared with non-septic ICU and healthy controls. In addition, the expressions of GPR174 mRNA were correlated with the lymphocyte (Lym) counts, C-reactive protein (CRP), and APACHE II and SOFA scores. The levels of GPR174 mRNA at Day 7 had a high AUC in predicting the death of sepsis (0.83). Further, we divided the septic patients into the higher and lower GPR174 mRNA expression groups by the ROC cut-off point, and the lower group was significantly associated with poor survival rate (P = 0.00139). Similarly, the expressions of peripheral Gpr174 mRNA in CLP-induced septic mice were also significantly decreased, and recovered after 72 h. Intriguingly, Gpr174-deficient could successfully improve the outcome with less multi-organ damage, which was mainly due to an increased level of IL-10, and decreased levels of IL-1β and TNF-α. Further, RNA-seq showed that Gpr174 deficiency significantly induced a phenotypic shift toward multiple immune response pathways in septic mice. In summary, our results indicated that the expressions of GPR174 mRNA were associated with the severity of sepsis, suggesting that GPR174 could be a potential prognosis biomarker for sepsis. In addition, GPR174 plays an important role in the development of sepsis by regulating the inflammatory response. Frontiers Media S.A. 2022-01-31 /pmc/articles/PMC8841418/ /pubmed/35173706 http://dx.doi.org/10.3389/fimmu.2021.789141 Text en Copyright © 2022 Wang, Hu, Kuang, Chen, Xing, Wei, Xue, Mu, Tong, Yang and Song https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Wang, Jianli Hu, Yanyan Kuang, Zhongshu Chen, Yao Xing, Lingyu Wei, Wei Xue, Mingming Mu, Sucheng Tong, Chaoyang Yang, Yilin Song, Zhenju GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response |
title |
GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response |
title_full |
GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response |
title_fullStr |
GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response |
title_full_unstemmed |
GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response |
title_short |
GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response |
title_sort | gpr174 mrna acts as a novel prognostic biomarker for patients with sepsis via regulating the inflammatory response |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841418/ https://www.ncbi.nlm.nih.gov/pubmed/35173706 http://dx.doi.org/10.3389/fimmu.2021.789141 |
work_keys_str_mv | AT wangjianli gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse AT huyanyan gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse AT kuangzhongshu gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse AT chenyao gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse AT xinglingyu gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse AT weiwei gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse AT xuemingming gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse AT musucheng gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse AT tongchaoyang gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse AT yangyilin gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse AT songzhenju gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse |